Key result
The Claret CE Pro cerebral protection device was feasible during TAVI, with a technical success rate of 60% for the first-generation and 87% for the second-generation device.
Why the study?
Is a novel cerebral embolic protection device feasible and safe in patients undergoing transcatheter aortic valve implantation?
Population
40 patients scheduled for transcatheter aortic valve implantation (TAVI)
Design
Cohort
Follow-up
30 days
Authors
Loading...
Supports further device development for TAVI embolic protection; randomized trials needed before clinical adoption.
Is a novel cerebral embolic protection device feasible and safe in patients undergoing transcatheter aortic valve implantation?
The first-in-human use of a novel cerebral protection device during TAVI demonstrated feasibility and safety, successfully capturing embolic debris in over half of the patients without procedural strokes.
Naber et al. (2012) studied Transcatheter aortic valve implantation (TAVI) (n=40). Claret CE Pro cerebral protection device was evaluated on Technical success rate. The Claret CE Pro cerebral protection device was feasible during TAVI, with a technical success rate of 60% for the first-generation and 87% for the second-generation device.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: